Ifzacort Tablet contains Deflazacort 6mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, and certain dermatological diseases. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing inflammation through inhibition of leukocyte infiltration, suppression of cytokine production, and stabilization of lysosomal membranes. Compared to other corticosteroids, Deflazacort is associated with a more favorable side effect profile, particularly regarding bone metabolism and glucose tolerance, making it a preferred option in long-term corticosteroid therapy. The recommended dosage of Ifzacort Tablet varies depending on the severity of the condition and patient response, and it should be administered under strict medical supervision to minimize potential adverse effects such as immunosuppression, hypertension, hyperglycemia, and osteoporosis. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; instead, gradual tapering is advised. Patients should be monitored regularly for therapeutic efficacy and side effects. Ifzacort Tablet is contraindicated in systemic fungal infections and hypersensitivity to deflazacort or any of its excipients. Caution is advised in patients with diabetes, hypertension, peptic ulcer disease, and psychiatric disorders.